Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout
5 months ago
R&D
How did Trump’s FDA pick land? Biotech stocks are up, and executives are (mostly) relieved
5 months ago
R&D
For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims
5 months ago
People
Pharma
Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks
5 months ago
People
FDA+
Kyowa Kirin acquires ex-US rights to Kura’s leukemia treatment for $330M upfront
5 months ago
Deals
Novo and Viking present new MASH data, but analysts remain confident in Madrigal's Rezdiffra
5 months ago
R&D
NICE has 'done all we can' to negotiate for Enhertu coverage, reaffirms decision not to recommend
5 months ago
Pharma
BeiGene settles final suit over future Brukinsa generics
5 months ago
Pharma
Law
Drugmakers 'not doing everything that they could' to widen global access, new report finds
5 months ago
Pharma
Vir, Bluejay invigorate hepatitis D space with new data
5 months ago
R&D
CSL Behring will close California office as part of shrinking ex vivo work
5 months ago
People
Cell/Gene Tx
Boston Pharmaceuticals hits Phase 2 goals as it tries to keep up with MASH competitors
5 months ago
R&D
Gilead will close Philadelphia, Seattle offices as part of job reductions
5 months ago
People
Pharma
Pfizer looking to sell hospital drugs unit — reports
6 months ago
Pharma
AstraZeneca CEO reaffirms commitment to China following executive's detention
6 months ago
China
Pharma
Intercept is denied full FDA approval for Ocaliva, but claims it will keep drug on market
6 months ago
Pharma
FDA+
FDA lifts hold on Novavax vaccines after adverse event reclassified as ALS
6 months ago
R&D
Pharma
GSK leaves biotech trade group BIO
6 months ago
Pharma
Eisai slashes Leqembi sales forecast by almost $100M
6 months ago
Pharma
Senior AstraZeneca exec detained in China amid wider investigation
6 months ago
People
China
Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum
6 months ago
Pharma
FDA+
Moderna reports slow start to RSV sales as Bancel steps back from commercial role
6 months ago
People
Pharma
One biotech is looking to lessen antipsychotic-induced weight gain, despite new entrants
6 months ago
R&D
Is there room for MASH drugs in a GLP-1 world?
6 months ago
R&D
Pharma
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page
